« Previous
Next »
The Journal of Pediatrics
Volume 149, Issue 5
, Pages
603-610.e1
, November 2006
Safety of reduced-antigen-content tetanus–diphtheria–acellular pertussis vaccine in adolescents as a sixth consecutive dose of acellular pertussis–containing vaccine
To access this article, please choose from the options below
Supported by GlaxoSmithKline Biologicals (study No. 100406).
This clinical trial was registered at www.clinicaltrials.gov (No. NCT00263679).
PII: S0022-3476(06)00553-1
doi: 10.1016/j.jpeds.2006.06.016
© 2006 Mosby, Inc. All rights reserved.
« Previous
Next »
The Journal of Pediatrics
Volume 149, Issue 5
, Pages
603-610.e1
, November 2006
